Skip to content
knowrare
HealthSignal
Your condition community

Living with Werdnig-Hoffmann disease

A genetic condition (spinal muscular atrophy type 1) that affects nerve cells controlling muscles, with signs in early infancy.

Understanding Werdnig-Hoffmann disease

Werdnig-Hoffmann disease (spinal muscular atrophy type 1) is a genetic condition that affects the nerve cells that control voluntary muscles.

Without treatment, symptoms appear before 6 months of age. They include worsening muscle weakness and low muscle tone, and may include feeding and breathing problems. GARD says SMA is now on the recommended newborn screening list in the United States, so it can be found before symptoms start.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Muscle weakness that worsens
  • Low muscle tone (hypotonia)
  • Poor head control
  • Feeding problems
  • Breathing problems and repeated respiratory infections
  • Tongue twitching

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include brain and nervous system specialists and genetic specialists.

  3. Consider genetic testing

    Changes in SMN1 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

  4. Connect with expert centers

    Muscular Dystrophy Association may keep lists of experts for this condition.

Care & treatment

Care team
Brain and nervous system specialists (neurologists); Genetic specialists (geneticists)
Expert care
Expert lists: Muscular Dystrophy Association
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Cure SMA and other patient organizations
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
Could SMN1 genetic testing confirm the diagnosis?
What treatments or supports are available for SMA1?
How can we plan for feeding and breathing care?

Quick facts

Symptoms usually startNewborn and as an Infant
InheritanceAutosomal Recessive
GenesSMN1

Werdnig-Hoffmann disease is caused by changes in the SMN1 gene. A child inherits a changed copy of the gene from each parent (autosomal recessive).

GeneticNeurological

Also known as: hereditary motor neuropathy proximal type i; hmn (hereditary motor neuropathy) proximal type i; infantile spinal muscular atrophy; infantile-onset spinal muscular atrophy; muscular atrophy, infantile; progressive muscular atrophy of infancy

Patient organizations

Source: NIH GARD · Werdnig-Hoffmann diseaseGARD ID 7883 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with Werdnig-Hoffmann disease.

Explore the Werdnig-Hoffmann disease blog

Explore research for Werdnig-Hoffmann disease

Explore actively recruiting Werdnig-Hoffmann disease studies with HealthSpark.

HealthSpark

Find actively recruiting studies for Werdnig-Hoffmann disease with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting Werdnig-Hoffmann disease studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for Werdnig-Hoffmann disease

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor Werdnig-Hoffmann disease

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your Werdnig-Hoffmann disease experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.